Science

hhmglobal.com

Jan 19, 2025, 07:23

The incidence of GEP-NETs in the US

JAMA Oncology posted on X about recent paper by Yazan Abboud et al., titled “Gastroenteropancreatic Neuroendocrine Tumor Incidence by Sex and Age in the US”.

Authors: Yazan Abboud, Anand Shah, Riya Sutariya, Vraj P. Shah, Ahmed Al-Khazraji, Paul J. Gaglio, Kaveh Hajifathalian

“The incidence of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in the US has increased over the past two decades, particularly in the appendix, pancreas, and small intestine.”

Ahmed Al-Khazraji Anand Shah cancer Gastroenteropancreatic Neuroendocrine Tumors JAMA Oncology Kaveh Hajifathalian OncoDaily Oncology Paul J. Gaglio Riya Sutariya Vraj P. Shah Yazan Abboud

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success